with the hereditary spinocerebellar ataxias (SCAs), but can usually be distinguished on a
clinical basis. We describe a patient who developed a sporadic, late‐onset, rapidly
progressive neurodegenerative disorder consistent with MSA‐C. Genetic testing, however,
showed an abnormal expansion of one allele of the spinocerebellar ataxia 3 (SCA3) gene.
The clinical impression of MSA‐C was confirmed by identification of numerous α‐synuclein …